Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Reetakshi, Arora"'
Autor:
Colin N. Haile, Kurt J. Varner, Xia Huijing, Reetakshi Arora, Frank M. Orson, Thomas R. Kosten, Therese A. Kosten
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1508 (2022)
Background: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects o
Externí odkaz:
https://doaj.org/article/b78660c9227a43e9b51847c33f5f5a46
Autor:
Yardena Samuels, David Adams, Alexandre Reuben, Jennifer Wargo, Adi Nagler, Shelly Kalaora, Deborah Gitta Rosenberg, Michal Alon, Eilon Barnea, Ronen Levy, Kevin Vervier, Sophie Trabish, Tali Dadosh, Smadar Zaidman, Leore Geller, Polina Greenberg, Neerupma Bhardwaj, Reetakshi Arora, Michal Lotem, Arie Admon, Yishai Levin, Trevor Lawley, Naama Geva-Zatorsky, Ravid Straussman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/b92cb62eef2f42a1b16f292fd71d3470
Autor:
Christoph K. Stein-Thoeringer, Neeraj Y. Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A. Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E. Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphael E. Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason Westin, Reetakshi Arora, Michael L. Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller-Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav
Publikováno v:
Nat Med
Increasing evidence suggests that the gut microbiome may modulate the efficacy of cancer immunotherapy. In a B cell-lymphoma patient cohort from five centers in Germany and the United States (Germany, N=66; US, N=106, Total, N=172), we demonstrate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b678db32d5c1d49ee86ffd70077e4ff
https://europepmc.org/articles/PMC10121864/
https://europepmc.org/articles/PMC10121864/
Autor:
Yifan Zhou, Yusra B. Medik, Bhakti Patel, Daniel B. Zamler, Sijie Chen, Thomas Chapman, Sarah Schneider, Elizabeth M. Park, Rachel L. Babcock, Taylor T. Chrisikos, Laura M. Kahn, Allison M. Dyevoich, Josue E. Pineda, Matthew C. Wong, Aditya K. Mishra, Samuel H. Cass, Alexandria P. Cogdill, Daniel H. Johnson, Sarah B. Johnson, Khalida Wani, Debora A. Ledesma, Courtney W. Hudgens, Jingjing Wang, Md Abdul Wadud Khan, Christine B. Peterson, Aron Y. Joon, Weiyi Peng, Haiyan S. Li, Reetakshi Arora, Ximing Tang, Maria Gabriela Raso, Xuegong Zhang, Wai Chin Foo, Michael T. Tetzlaff, Gretchen E. Diehl, Karen Clise-Dwyer, Elizabeth M. Whitley, Matthew M. Gubin, James P. Allison, Patrick Hwu, Nadim J. Ajami, Adi Diab, Jennifer A. Wargo, Stephanie S. Watowich
Publikováno v:
The Journal of experimental medicine. 220(2)
Immune checkpoint blockade (ICB) has revolutionized cancer treatment, yet quality of life and continuation of therapy can be constrained by immune-related adverse events (irAEs). Limited understanding of irAE mechanisms hampers development of approac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3f2ab36b1e8f26732341aaaebcd8d1
https://pubmed.ncbi.nlm.nih.gov/36367776
https://pubmed.ncbi.nlm.nih.gov/36367776
Autor:
Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan, John A. McCulloch, Marie Vetizou, Alexandria P. Cogdill, Md A. Wadud Khan, Xiaotao Zhang, Michael G. White, Christine B. Peterson, Matthew C. Wong, Golnaz Morad, Theresa Rodgers, Jonathan H. Badger, Beth A. Helmink, Miles C. Andrews, Richard R. Rodrigues, Andrey Morgun, Young S. Kim, Jason Roszik, Kristi L. Hoffman, Jiali Zheng, Yifan Zhou, Yusra B. Medik, Laura M. Kahn, Sarah Johnson, Courtney W. Hudgens, Khalida Wani, Pierre-Olivier Gaudreau, Angela L. Harris, Mohamed A. Jamal, Erez N. Baruch, Eva Perez-Guijarro, Chi-Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert A. Szczepaniak-Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A. S. Anang, Sheila Duncan, Joseph Toker, Jared C. Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, Vanessa Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo
Publikováno v:
Science (New York, N.Y.). 374(6575)
Another benefit of dietary fiber The gut microbiome can modulate the immune system and influence the therapeutic response of cancer patients, yet the mechanisms underlying the effects of microbiota are presently unclear. Spencer et al . add to our un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333675406957cdc475454320562634b6
https://pubmed.ncbi.nlm.nih.gov/35235771
https://pubmed.ncbi.nlm.nih.gov/35235771
Autor:
Catalin Mihalcioiu, Charlotte E. Ariyan, Michael K. Wong, Aurélie Fluckiger, Julie M. Simon, Rossanna C. Pezo, Michael G. White, Padmanee Sharma, Michael A. Postow, Sapna Pradyuman Patel, Adi Diab, Isabella C. Glitza, Elizabeth M. Burton, Whijae Roh, Zachary A. Cooper, Laurence Zitvogel, Maria Paula Roberti, Wen-Jen Hwu, Alexandria P. Cogdill, Miles C. Andrews, Gladys Ferrere, Abdul Wadud Khan, Scott E. Woodman, Robert R. Jenq, Christine N. Spencer, James P. Allison, Lisa Derosa, Curtis Gumbs, Wei Shen Chen, Stephanie S. Watowich, Irina Fernandez Curbelo, Michael A. Davies, Paule Opolon, Connie P.M. Duong, Jennifer A. Wargo, Maryam Tidjani Alou, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Pierre Olivier Gaudreau, Michael T. Tetzlaff, Didier Raoult, Arielle Elkrief, Khalida Wani, Jeffrey E. Gershenwald, Margaret K. Callahan, Sarah B. Johnson, Alexandre Reuben, Joseph F. Petrosino, Latasha Little, Peter A. Prieto, Matthew Lastrapes, Valerio Iebba, Bertrand Routy, Matthew Adamow, Alexander J. Lazar, Jennifer L. McQuade, Nadim J. Ajami, Golnaz Morad, Rodabe N. Amaria, Matthew C. Wong, Erez N. Baruch, Hussein Abdul-Hassan Tawbi, Satoru Yonekura, Li Zhao, Reetakshi Arora, Luis M Vence, Lauren E. Haydu, Luigi Nezi, Patrick Hwu, P. Andrew Futreal, Jianhua Zhang
Publikováno v:
Nature Medicine
Nature Medicine, 2021, 27 (8), pp.1432-1441. ⟨10.1038/s41591-021-01406-6⟩
Nature Medicine, Nature Publishing Group, 2021, 27 (8), pp.1432-1441. ⟨10.1038/s41591-021-01406-6⟩
Nature Medicine, 2021, 27 (8), pp.1432-1441. ⟨10.1038/s41591-021-01406-6⟩
Nature Medicine, Nature Publishing Group, 2021, 27 (8), pp.1432-1441. ⟨10.1038/s41591-021-01406-6⟩
International audience; Treatment with combined immune checkpoint blockade (CICB) targeting CTLA-4 and PD-1 is associated with clinical benefit across tumor types, but also a high rate of immune-related adverse events. Insights into biomarkers and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b68bdb823308a5d01ebdad2aabf30e
https://hal-amu.archives-ouvertes.fr/hal-03333724/file/2f0091ab-846d-4b59-9960-dcea2f6edc58.pdf
https://hal-amu.archives-ouvertes.fr/hal-03333724/file/2f0091ab-846d-4b59-9960-dcea2f6edc58.pdf
Autor:
Yan Wu, Frank M. Orson, Lynn D. Hawkins, Colin N. Haile, Reetakshi Arora, Thomas R. Kosten, Therese A. Kosten, Muthu Ramakrishnan
Publikováno v:
The American Journal on Addictions. 28:119-126
BACKGROUND AND OBJECTIVE Methamphetamine (MA) substance use disorder (SUD) does not have an efficacious pharmacotherapy. We developed a MA vaccine and investigated its potential to attenuate MA induced responses. METHODS We examined a novel adjuvant,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ffba3f111f6fe62efb4443df07491c7
https://doi.org/10.1111/ajad.12867
https://doi.org/10.1111/ajad.12867
Autor:
Adi Nagler, Kuoyuan Cheng, Alexandre Reuben, Kun Wang, Deborah Nejman, Mitchell P. Levesque, Maya Lotan-Pompan, Ron Rotkopf, Chantale Bernatchez, Adina Weinberger, Jessica Galloway-Peña, Ronen Levy, Sarah B. Johnson, Scott N. Peterson, Jennifer A. Wargo, Jacob Schachter, Yardena Samuels, Aviyah Peri, Polina Greenberg, Tali Dadosh, Leandro C. Hermida, Ofra Golani, Eilon Barnea, Noam Shental, Naama Geva-Zatorsky, Yishai Levin, Lior Roitman, Garold Fuks, David J. Adams, Eran Segal, Leore T. Geller, William C Shropshire, Cara Haymaker, Raya Eilam, Ravid Straussman, Michal Lotem, Kevin Vervier, Chaya Barbolin, Neerupma Bhardwaj, Smadar Levin-Zaidman, Arie Admon, Yuval Bussi, Gal Yagel, Michal Alon, Eytan Ruppin, Gil Benedek, Steven L. C. Ketelaars, Shelly Kalaora, Trevor D. Lawley, Sophie Trabish, Reetakshi Arora, Pia Kvistborg, Michal J. Besser
Publikováno v:
Nature
A variety of species of bacteria are known to colonize human tumours1–11, proliferate within them and modulate immune function, which ultimately affects the survival of patients with cancer and their responses to treatment12–14. However, it is no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4e3a8e26499995bc3104dc84f785da
https://europepmc.org/articles/PMC9717498/
https://europepmc.org/articles/PMC9717498/
Autor:
Yifan Zhou, Yusra B. Medik, Bhakti Patel, Daniel B. Zamler, Sijie Chen, Thomas Chapman, Sarah Schneider, Rachel L. Babcock, Taylor T. Chrisikos, Laura M. Kahn, Allison M. Dyevoich, Elizabeth M. Park, Alexandria P. Cogdill, Daniel H. Johnson, Sarah B. Johnson, Khalida M. Wani, Debora A. Ledesma, Courtney W. Hudgens, Jingjing Wang, Md Abdul Wadud Khan, Aron Y. Joon, Weiyi Peng, Haiyan S. Li, Reetakshi Arora, Ximing Tang, Maria Gabriela Raso, Xuegong Zhang, Wai Chin Foo, Michael T. Tetzlaff, Gretchen E. Diehl, Karen Clise-Dwyer, Elizabeth M. Whitley, Matthew M. Gubin, James P. Allison, Patrick Hwu, Nadim J. Ajami, Adi Diab, Jennifer A. Wargo, Stephanie S. Watowich
Publikováno v:
Cancer Research. 82:5545-5545
Immunotherapies such as anti-CTLA-4 immune checkpoint blockade (ICB) have revolutionized cancer treatment, yet quality of life and continuation of therapy can be constrained by off-target tissue damage or immune-related adverse events (irAEs). At pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf704eac5d3866abb91b36de3d854cb6
https://doi.org/10.1158/1538-7445.am2022-5545
https://doi.org/10.1158/1538-7445.am2022-5545
Autor:
Jennifer Wargo, Miles Andrews, Connie Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, Wei-Shen Chen, Lisa Derosa, Bertrand Routy, Gladys Ferrere, Aurélie Fluckiger, Maria Roberti, Paule Opolon, Whijae Roh, Christine Spencer, Irina Fernandez Curbelo, Luis Vence, Alexandre Reuben, Zachary Cooper, Peter Prieto, M. A. Wadud Khan, Alexander Lazar, Michael Tetzlaff, Courtney Hudgens, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Lauren Haydu, Hussein Tawbi, Patrick Hwu, Wen-Jen Hwu, Rodabe Amaria, Elizabeth Burton, Scott Woodman, Adi Diab, Sapna Patel, Isabella Glitza, Jianhua Zhang, Nadim Ajami, Joseph Petrosino, Robert Jenq, Michael Davies, Jeffrey Gershenwald, Padmanee Sharma, James Allison, Andrew Futreal, Laurence Zitvogel, Maryam TIDJANI ALOU, Satoru Yonekura, Alexandria Cogdill, Reetakshi Arora, Latasha Little, Curtis Gumbs, Khalida Wani, Margaret Callahan, Mathew Adamow, Michael Postow, Charlotte Ariyan, Julie Gardner, Jennifer McQuade, Michael Wong, Li Zhao
Treatment with combined immune checkpoint blockade (CICB) targeting CTLA-4 and PD-1 is associated with clinical benefit across tumor types, but a high rate of immune-related adverse events (irAE). Insights into biomarkers and mechanisms of response a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24dcf02e4ee91c54a0239c73fe7cba34
https://doi.org/10.21203/rs.3.rs-119925/v1
https://doi.org/10.21203/rs.3.rs-119925/v1